CN Patent

CN108289959B — 用于治疗脊髓性肌萎缩的组合物

Assigned to F Hoffmann La Roche AG · Expires 2021-07-16 · 5y expired

What this patent protects

本发明提供包含式(I)的化合物及其药用盐的药物组合物，其中A、R 1 、R 2 和R 3 如本文中所述。本发明还涉及包含式(I)的化合物的药物组合物的制备及其作为药物的用途。

USPTO Abstract

本发明提供包含式(I)的化合物及其药用盐的药物组合物，其中A、R 1 、R 2 和R 3 如本文中所述。本发明还涉及包含式(I)的化合物的药物组合物的制备及其作为药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN108289959B
Jurisdiction
CN
Classification
—
Expires
2021-07-16
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.